Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1882 of 5804
-
New pill combo shows promise in shrinking breast tumors before surgery
Disease control CompletedThe purpose of this study is to learn about the effects of the study medicine PF-07220060 plus letrozole, compared with the effects of taking letrozole alone without PF-07220060 for treatment of breast cancer. This study is seeking for participants who are: * women of age 18 ye…
Phase: PHASE2 • Sponsor: Pfizer • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
New pill shows promise in early trial for Hard-to-Treat cancers
Disease control Recruiting nowThis is a phase 1, open-label, dose-escalation study to evaluate the safety, tolerability, pharmacokinetic (PK), pharmacodynamic (PD) characteristics and initial anti-tumor activity of IPG1094 in patients with advanced solid tumors. The study will be conducted in two parts: dose …
Phase: PHASE1, PHASE2 • Sponsor: Nanjing Immunophage Biotech Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Mapping the Brain's hidden damage after radiation in kids
Knowledge-focused Recruiting nowWith modern therapy, the survival rate for pediatric brain tumor patients has significantly improved, with over 70% of patients surviving their disease. However, this progress often comes at the cost of substantial morbidity, with cognitive deficits being the primary obstacle to …
Sponsor: Washington University School of Medicine • Aim: Knowledge-focused
Last updated Jul 19, 2026 00:00 UTC
-
New biweekly shot could help control blood sugar in type 2 diabetes
Disease control OngoingThe main purpose of this study is to investigate the efficacy and safety of JY09 versus placebo in patients with type 2 diabetes mellitus (T2DM) inadequately controlled by diet and exercise alone
Phase: PHASE3 • Sponsor: Beijing Dongfang Biotech Co., Ltd. • Aim: Disease control
Last updated Jun 26, 2026 17:31 UTC
-
Light and sound waves ease diabetic nerve pain in new study
Symptom relief CompletedThis study aims: * To compare conventional diabetic neuropathy screening techniques with user-friendly technological equipment; * To evaluate the effects of the combined application of laser and therapeutic ultrasound in the treatment of Diabetic Peripheral Neuropathy (DPN) in i…
Phase: NA • Sponsor: University of Sao Paulo • Aim: Symptom relief
Last updated Jun 27, 2026 08:10 UTC
-
Can a brief online therapy ease anxiety and depression in kids? new study aims to find out.
Symptom relief ENROLLING_BY_INVITATIONThe goal of this clinical trial is to test a brief, behavioral telehealth treatment program (STEP-UP) for depression and anxiety in youths (age 8-16 years old). Youths and families will be recruited through participating community health centers and will be randomly assigned to e…
Phase: NA • Sponsor: San Diego State University • Aim: Symptom relief
Last updated Jun 27, 2026 12:07 UTC
-
Apple watch AI could spot hidden heart trouble
Diagnosis CompletedObservational, non-interventional, prospective, open-label, single-center, non-randomized study of a CE-marked medical device used in its intended purpose.
Sponsor: RCF@ICPS • Aim: Diagnosis
Last updated Jun 27, 2026 13:00 UTC
-
Shining a light on cancer fatigue: bright light therapy tested in prostate cancer trial
Symptom relief Recruiting nowThis phase II trial tests how well bright white light (BWL) therapy works in reducing cancer-related fatigue and depression in patients with prostate cancer that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced) and…
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 07:53 UTC
-
New heart device tested in everyday use to seal birth defects
Disease control Recruiting nowThe objective of this post-market registry is to assess the clinical use of the Lifetech CeraFlex™ Closure System in a real-world and on-label fashion.
Sponsor: Lifetech Scientific (Shenzhen) Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New cholesterol drug MK-0616 takes on old favorites in Head-to-Head trial
Disease control CompletedThe main purpose of this study is to assess whether enlicitide is superior to ezetimibe or bempedoic acid or ezetimibe + bempedoic acid in reducing low-density lipoprotein cholesterol (LDL-C) in participants with hypercholesterolemia, and to evaluate its safety and tolerability. …
Phase: PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Can acupuncture and herbs restore hearing? new study explores integrative approach
Symptom relief Recruiting nowSudden hearing loss is an emergency in otolaryngology that requires diagnosis and treatment as soon as possible. The golden treatment period is two weeks since the onset of the disease. However, modern medicine is still unable to fully understand the causes of the disease and in …
Phase: NA • Sponsor: China Medical University Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 07:58 UTC
-
New hair loss pill shows promise in early trial
Disease control OngoingThis study will evaluate the safety and efficacy of VDPHL01 in male and female subjects with Androgenetic Alopecia (AGA). AGA (or pattern of hair loss) is a genetic disorder caused by an excessive (too much) hair follicle response to androgens (hormone) that causes hair loss. VD…
Phase: PHASE2 • Sponsor: Veradermics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
5,000-Patient study aims to unlock sarcoidosis mysteries
Knowledge-focused Recruiting nowThere is no cure for the inflammatory disease sarcoidosis. Virtually any part of the body can be affected but most often the lungs and lymph nodes. Outcomes after diagnosis vary widely among sarcoidosis patients, with some experiencing resolving disease and others developing chro…
Sponsor: Region Stockholm • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:11 UTC
-
Custom plastic implant may offer better relief for chronic jaw dislocation
Disease control OngoingDoes patient specific Ultra-High Molecular Weight Polyethylene implant eminoplasty will decrease maximum interincisal distance, provide better soft tissue response and post-operative patient satisfaction than patient specific Titanium eminoplasty in treatment of chronic condylar …
Phase: NA • Sponsor: Cairo University • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
New study tests propofol vs spinal analgesia for breech baby turn
Symptom relief Recruiting nowExternal Cephalic Version (ECV) is a maneuver to modify fetal position in pregnant women with a non-cephalic presentation. Its objective is to achieve a cephalic presentation that allows for vaginal delivery with less risk than a vaginal breech delivery or a cesarean section. ECV…
Phase: NA • Sponsor: Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia • Aim: Symptom relief
Last updated Jun 27, 2026 07:59 UTC
-
New heart pump gives hope to advanced heart failure patients
Disease control CompletedFeasibility study of the DuoCor Ventricular Assist System as a treatment for advanced total heart failure patients.
Phase: NA • Sponsor: Shenzhen Core Medical Technology CO.,LTD. • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New device aims to prevent blocked arteries during repeat heart valve surgery
Disease control CompletedA Prospective, Multicenter, Non-Randomized, Single-Arm, Open-Label Continued Access Study of the ShortCut™ device (The ShortCut™ CAS).
Phase: NA • Sponsor: Pi-cardia • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
New hope for advanced cancer: experimental drug combo enters human trials
Disease control Recruiting nowThis study is an open-label, multicenter Phase IB/II clinical trial to evaluate the safety, tolerability and efficacy of SHR-9839 for injection in combination with other antitumor therapies in patients with advanced solid tumors.
Phase: PHASE1, PHASE2 • Sponsor: Shanghai Hengrui Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
New pain drug may cut Post-Surgery nausea
Symptom relief CompletedPostoperative nausea and vomiting (PONV) is common after surgery and impede rapid recovery after surgery. Patients who undergo laparoscopic colorectal surgery are more likely to develop PONV due to the pneumoperitoneum, interruption of gastrointestinal system, delay of oral feedi…
Phase: PHASE4 • Sponsor: Peking University First Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 14:02 UTC
-
New shot takes aim at stubborn high cholesterol
Disease control CompletedEvaluation of the efficacy and safety of multiple subcutaneous injections of SHR-1918 in patients with hyperlipidemia in poor control: a multicenter, randomized, double-blind, placebo-controlled phase II clinical trials
Phase: PHASE2 • Sponsor: Beijing Suncadia Pharmaceuticals Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC